N-(3-benzoylphenyl)-1H-indole-2-carboxamide

ID: ALA3799956

Chembl Id: CHEMBL3799956

PubChem CID: 56325569

Max Phase: Preclinical

Molecular Formula: C22H16N2O2

Molecular Weight: 340.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1ccccc1)c1cccc(NC(=O)c2cc3ccccc3[nH]2)c1

Standard InChI:  InChI=1S/C22H16N2O2/c25-21(15-7-2-1-3-8-15)17-10-6-11-18(13-17)23-22(26)20-14-16-9-4-5-12-19(16)24-20/h1-14,24H,(H,23,26)

Standard InChI Key:  NIFJNLTXXJIUNG-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 340.38Molecular Weight (Monoisotopic): 340.1212AlogP: 4.65#Rotatable Bonds: 4
Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.90CX Basic pKa: CX LogP: 4.54CX LogD: 4.54
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.53Np Likeness Score: -1.08

References

1. Sweidan K, Sabbah DA, Bardaweel S, Dush KA, Sheikha GA, Mubarak MS..  (2016)  Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors.,  26  (11): [PMID:27084677] [10.1016/j.bmcl.2016.04.011]

Source